Integra LifeSciences Holdings Operating Margin 2010-2024 | IART

Current and historical operating margin for Integra LifeSciences Holdings (IART) over the last 10 years. The current operating profit margin for Integra LifeSciences Holdings as of September 30, 2024 is 12.32%.
Integra LifeSciences Holdings Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-09-30 $1.57B $0.03B 1.85%
2024-06-30 $1.57B $0.06B 4.09%
2024-03-31 $1.53B $0.08B 5.23%
2023-12-31 $1.54B $0.11B 7.27%
2023-09-30 $1.54B $0.14B 9.34%
2023-06-30 $1.55B $0.18B 11.78%
2023-03-31 $1.56B $0.23B 14.66%
2022-12-31 $1.56B $0.24B 15.34%
2022-09-30 $1.57B $0.23B 14.62%
2022-06-30 $1.57B $0.22B 14.03%
2022-03-31 $1.56B $0.21B 13.59%
2021-12-31 $1.54B $0.20B 12.77%
2021-09-30 $1.53B $0.19B 12.58%
2021-06-30 $1.51B $0.19B 12.86%
2021-03-31 $1.38B $0.16B 11.32%
2020-12-31 $1.37B $0.15B 11.08%
2020-09-30 $1.38B $0.14B 9.80%
2020-06-30 $1.39B $0.06B 4.04%
2020-03-31 $1.51B $0.09B 5.82%
2019-12-31 $1.52B $0.09B 6.13%
2019-09-30 $1.51B $0.09B 6.04%
2019-06-30 $1.49B $0.14B 9.11%
2019-03-31 $1.48B $0.12B 8.00%
2018-12-31 $1.47B $0.11B 7.61%
2018-09-30 $1.46B $0.09B 5.83%
2018-06-30 $1.37B $0.07B 5.25%
2018-03-31 $1.29B $0.06B 4.74%
2017-12-31 $1.19B $0.05B 3.78%
2017-09-30 $1.08B $0.08B 7.34%
2017-06-30 $1.05B $0.10B 9.36%
2017-03-31 $1.01B $0.10B 10.16%
2016-12-31 $0.99B $0.12B 11.59%
2016-09-30 $0.98B $0.10B 10.03%
2016-06-30 $0.95B $0.08B 8.18%
2016-03-31 $0.92B $0.08B 8.72%
2015-12-31 $0.88B $0.08B 8.95%
2015-09-30 $0.80B $0.09B 10.69%
2015-06-30 $0.77B $0.09B 11.99%
2015-03-31 $0.79B $0.08B 10.19%
2014-12-31 $0.80B $0.07B 8.53%
2014-09-30 $0.73B $0.10B 13.93%
2014-06-30 $0.74B $0.05B 7.16%
2014-03-31 $0.72B $0.05B 6.57%
2013-12-31 $0.70B $0.04B 5.16%
2013-09-30 $0.83B $-0.01B -0.96%
2013-06-30 $0.83B $0.04B 5.20%
2013-03-31 $0.83B $0.06B 6.62%
2012-12-31 $0.83B $0.07B 8.92%
2012-09-30 $0.82B $0.06B 7.68%
2012-06-30 $0.81B $0.06B 7.51%
2012-03-31 $0.80B $0.05B 6.42%
2011-12-31 $0.78B $0.06B 7.05%
2011-09-30 $0.77B $0.07B 9.22%
2011-06-30 $0.76B $0.08B 10.60%
2011-03-31 $0.74B $0.10B 13.09%
2010-12-31 $0.73B $0.10B 13.51%
2010-09-30 $0.72B $0.10B 14.25%
2010-06-30 $0.71B $0.10B 14.12%
2010-03-31 $0.70B $0.10B 14.24%
2009-12-31 $0.68B $0.10B 14.35%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.860B $1.542B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.293B 24.68
Intuitive Surgical (ISRG) United States $195.881B 102.41
Edwards Lifesciences (EW) United States $43.763B 27.79
Alcon (ALC) Switzerland $43.327B 28.99
IQVIA Holdings (IQV) United States $36.875B 20.32
IDEXX Laboratories (IDXX) United States $35.573B 41.89
DexCom (DXCM) United States $31.642B 47.65
Waters (WAT) United States $23.237B 34.36
STERIS (STE) Ireland $21.444B 24.69
SONOVA HOLDING (SONVY) Switzerland $20.134B 0.00
Hologic (HOLX) United States $17.445B 18.84
Fresenius Medical Care AG KGaA (FMS) Germany $13.790B 14.16
Sysmex ADR (SSMXY) Japan $13.236B 41.51
Globus Medical (GMED) United States $11.494B 29.11
Penumbra (PEN) United States $9.559B 93.64
Masimo (MASI) United States $9.193B 44.48
Teleflex (TFX) United States $8.700B 13.88
Glaukos (GKOS) United States $7.624B 0.00
PROCEPT BioRobotics (PRCT) United States $5.190B 0.00
Integer Holdings (ITGR) United States $4.713B 26.71
Veracyte (VCYT) United States $3.417B 102.54
Inari Medical (NARI) United States $3.056B 0.00
LivaNova (LIVN) United Kingdom $2.780B 16.05
TransMedics (TMDX) United States $2.423B 76.82
Nihon Kohden (NHNKY) Japan $2.410B 18.31
Elekta AB (EKTAY) Sweden $2.150B 19.33
Tandem Diabetes Care (TNDM) United States $2.120B 0.00
RxSight (RXST) United States $1.740B 0.00
Alphatec Holdings (ATEC) United States $1.425B 0.00
Artivion (AORT) United States $1.243B 82.36
Pulse Biosciences (PLSE) United States $1.217B 0.00
OPKO Health (OPK) United States $1.065B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.878B 14.92
Paragon 28 (FNA) United States $0.830B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.716B 0.00
IRadimed (IRMD) United States $0.693B 37.48
Mesa Laboratories (MLAB) United States $0.686B 16.17
AxoGen (AXGN) United States $0.653B 0.00
OrthoPediatrics (KIDS) United States $0.591B 0.00
SiBone (SIBN) United States $0.578B 0.00
Pacific Biosciences Of California (PACB) United States $0.570B 0.00
Semler Scientific (SMLR) United States $0.525B 30.93
Treace Medical Concepts (TMCI) United States $0.502B 0.00
Tactile Systems Technology (TCMD) United States $0.456B 24.70
Delcath Systems (DCTH) United States $0.365B 0.00
CVRx (CVRX) United States $0.359B 0.00
ClearPoint Neuro (CLPT) United States $0.351B 0.00
NeuroPace (NPCE) United States $0.334B 0.00
AngioDynamics (ANGO) United States $0.290B 0.00
Inogen (INGN) United States $0.243B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Accuray (ARAY) United States $0.204B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.181B 0.00
Nevro (NVRO) United States $0.155B 0.00
Atossa Genetics (ATOS) United States $0.147B 0.00
Sensus Healthcare (SRTS) United States $0.142B 15.16
Spectral Diagnostics (EDTXF) Canada $0.110B 0.00
Vicarious Surgical (RBOT) United States $0.097B 0.00
LENSAR (LNSR) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.086B 0.00
908 Devices (MASS) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.085B 0.00
Monogram Orthopaedics (MGRM) United States $0.081B 0.00
Covalon Technologies (CVALF) Canada $0.074B 0.00
InspireMD (NSPR) Israel $0.074B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.052B 0.00
Rapid Micro Biosystems (RPID) United States $0.046B 0.00
Accelerate Diagnostics (AXDX) United States $0.043B 0.00
Envoy Medical (COCH) United States $0.043B 0.00
Spectral AI (MDAI) United States $0.040B 0.00
Neuronetics (STIM) United States $0.036B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
NexGel (NXGL) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Baird Medical Investment Holdings (BDMD) $0.014B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00